GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASMB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Assembly Biosciences stock after gaining 3.17%
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Gain 3.17% PDF

The Assembly Biosciences stock price gained 3.17% on the last trading day (Thursday, 18th Apr 2024), rising from $12.92 to $13.33. During the last trading day the stock fluctuated 7.50% from a day low at $12.40 to a day high of $13.33. The price has risen in 6 of the last 10 days but is still down by -2.27% for this period. Volume fell on the last day by -10 thousand shares and in total, 17 thousand shares were bought and sold for approximately $222.46 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $12.34 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 423.96% during the next 3 months and, with a 90% probability hold a price between $64.64 and $96.76 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASMB Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Assembly Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $14.30 and $13.35. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -11.49%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Assembly Biosciences stock

Assembly Biosciences finds support from accumulated volume at $13.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.93 between high and low, or 7.50%. For the last week the stock has had daily average volatility of 7.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ASMB) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Assembly Biosciences to open at $13.02, and during the day (based on 14 day Average True Range), to move between $12.52 and $14.14, which gives a possible trading interval of +/-$0.81 (+/-6.08%) up or down from last closing price. If Assembly Biosciences takes out the full calculated possible swing range there will be an estimated 12.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.20 (0.98%) than the resistance at $13.47 (1.05%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Assembly Biosciences stock A Buy?

The Assembly Biosciences stock holds several negative signals and despite the positive trend, we believe Assembly Biosciences will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.081 Sell Candidate Unchanged

Predicted Opening Price for Assembly Biosciences of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$13.02 ( 2.33%) $13.33

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASMB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.95 4.65 %
R2 13.59 1.99 %
R1 13.38 0.340 %
Current price: 13.33
Support S1 12.66 -4.99 %
S2 12.45 -6.64 %
S3 12.09 -9.30 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.79 3.45 %
R2 13.50 1.28 %
R1 13.47 1.05 %
Current price 13.33
Support S1 13.20 -0.98%
S2 12.35 -7.35%
S3 12.27 -7.95%

FAQ

What is the symbol for Assembly Biosciences Stock and on which exchange is it traded?
The symbol for Assembly Biosciences is ASMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Assembly Biosciences Stock?
The Assembly Biosciences stock holds several negative signals and despite the positive trend, we believe Assembly Biosciences will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Assembly Biosciences Stock?
Assembly Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Assembly Biosciences Stock.

What's the current price of Assembly Biosciences Stock?
As of the end of day on the 2024-04-18, the price of an Assembly Biosciences (ASMB) share was $13.33.

What is the 52-week high and low for Assembly Biosciences Stock?
The 52-week high for Assembly Biosciences Stock is $15.18 and the 52-week low is $0.641.

What is the market capitalization of Assembly Biosciences Stock?
As of the 2024-04-18, the market capitalization of Assembly Biosciences is 70.837M.

When is the next earnings date for Assembly Biosciences?
The upcoming earnings date for Assembly Biosciences is May 02, 2024.
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT